Transactivation of the human NME5 gene by Sp1 in pancreatic cancer cells

Gene

Volumn 503, Issue 2, 2012, Pages 200-207

  Li, Fu ^a   Jiang, Zhenzhou ^a   Wang, Ke ^b   Guo, Jingjing ^a   Hu, Gang ^a,b   Sun, Lixin ^a   Wang, Tao ^a   Tang, Xuzhen ^a,b   He, Ling ^a   Yao, Jincheng ^c   Wen, Danyi ^b   Qin, Xiaoran ^b   Zhang, Luyong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b Shanghai ChemPartner Co Ltd   (China)

^c Hunan Center for Drug Evaluation and ADR Monitoring   (China)

Author keywords

NME5; Pancreatic cancer; Promoter; Sp1; Transactivation

Indexed keywords

NUCLEOSIDE DIPHOSPHATE KINASE; NUCLEOSIDE DIPHOSPHATE KINASE NME5; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA BASE COMPOSITION; DNA FLANKING REGION; GENE MUTATION; HUMAN; HUMAN CELL; OPEN READING FRAME; PANCREAS CANCER; PRIORITY JOURNAL; PROMOTER REGION; START CODON; TRANSACTIVATION; TRANSCRIPTION INITIATION SITE; TRANSLATION INITIATION;

BASE SEQUENCE; CELL LINE, TUMOR; DEOXYCYTIDINE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; PANCREATIC NEOPLASMS; PROMOTER REGIONS, GENETIC; REGULATORY SEQUENCES, NUCLEIC ACID; SEQUENCE ANALYSIS, DNA; SP1 TRANSCRIPTION FACTOR; SP3 TRANSCRIPTION FACTOR; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

AGOUTI PACA;

EID: 84861834970     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.04.088     Document Type: Article

References (26)

1. Cervoni L., et al. DNA sequences acting as binding sites for NM23/NDPK proteins in melanoma M14 cells. J. Cell. Biochem. 2006, 98:421-428.
2. Chapman E.J., Kelly G., Knowles M.A. Genes involved in differentiation, stem cell renewal, and tumorigenesis are modulated in telomerase-immortalized human urothelial cells. Mol. Cancer Res. 2008, 6:1154-1168.
3. Deplagne C., et al. The anti-metastatic nm23-1 gene is needed for the final step of mammary duct maturation of the mouse nipple. PLoS One 2011, 6:e18645.
4. Desvignes T., Pontarotti P., Bobe J. Nme gene family evolutionary history reveals pre-metazoan origins and high conservation between humans and the sea anemone, Nematostella vectensis. PLoS One 2010, 5:e15506.
5. Faisst S., Meyer S. Compilation of vertebrate-encoded transcription factors. Nucleic Acids Res. 1992, 20:3-26.
6. Gao Y., et al. Combining betulinic acid and mithramycin a effectively suppresses pancreatic cancer by inhibiting proliferation, invasion, and angiogenesis. Cancer Res. 2011, 71:5182-5193.
7. Gibson S., Shillitoe E.J. Analysis of apoptosis-associated genes and pathways in oral cancer cells. J. Oral Pathol. Med. 2006, 35:146-154.
8. Hamada S., et al. The homeobox gene MSX2 determines chemosensitivity of pancreatic cancer cells via the regulation of transporter gene ABCG2. J. Cell. Physiol. 2012, 227:729-738.
9. Hu G., et al. Intrinsic gemcitabine resistance in a novel pancreatic cancer cell line. Int. J. Oncol. 2011, 7:1254.
10. Jutooru I., et al. Methyl 2-cyano-3,12-dioxooleana-1,9-dien-28-oate decreases specificity protein transcription factors and inhibits pancreatic tumor growth: role of microRNA-27a. Mol. Pharmacol. 2010, 78:226-236.
11. Jutooru I., et al. Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation. J. Biol. Chem. 2010, 285:25332-25344.
12. Kadonaga J.T., et al. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell 1987, 51:1079-1090.
13. Kharbanda S., et al. Functional interaction between DNA-PK and c-Abl in response to DNA damage. Nature 1997, 386:732-735.
14. Kumar A.P., Butler A.P. Transcription factor Sp3 antagonizes activation of the ornithine decarboxylase promoter by Sp1. Nucleic Acids Res. 1997, 25:2012-2019.
15. Lacombe M.L., et al. The human Nm23/nucleoside diphosphate kinases. J. Bioenerg. Biomembr. 2000, 32:247-258.
16. Li F., et al. Cytotoxic effects and pro-apoptotic mechanism of TBIDOM, a novel dehydroabietylamine derivative, on human hepatocellular carcinoma SMMC-7721 cells. J. Pharm. Pharmacol. 2008, 60:205-211.
17. Li F., et al. Identification of NME5 as a contributor to innate resistance to gemcitabine in pancreatic cancer cells. FEBS J. 2012, 279:1261-1273.
18. Munier A., et al. A new human nm23 homologue (nm23-H5) specifically expressed in testis germinal cells. FEBS Lett. 1998, 434:289-294.
19. Munier A., et al. Nm23/NDP kinases in human male germ cells: role in spermiogenesis and sperm motility?. Exp. Cell Res. 2003, 289:295-306.
20. Munoz-Dorado J., Inouye S., Inouye M. Nucleoside diphosphate kinase from Myxococcus xanthus. II. Biochemical characterization. J. Biol. Chem. 1990, 265:2707-2712.
21. Nakamori S., et al. Expression of nucleoside diphosphate kinase/nm23 gene product in human pancreatic cancer: an association with lymph node metastasis and tumor invasion. Clin. Exp. Metastasis 1993, 11:151-158.
22. Perina D., et al. Sponge non-metastatic Group I Nme gene/protein - structure and function is conserved from sponges to humans. BMC Evol. Biol. 2011, 11:87-98.
23. Shi Q., et al. Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Res. 2001, 61:4143-4154.
24. Suske G. The Sp-family of transcription factors. Gene 1999, 238:291-300.
25. Wobus M., et al. Transcriptional regulation of the human CD97 promoter by Sp1/Sp3 in smooth muscle cells. Gene 2008, 413:67-75.
26. Zhang W., et al. Functional and sequence analysis of human neuroglobin gene promoter region. Biochim. Biophys. Acta 2011, 1809:236-244.